COMMUNIQUÉS West-GlobeNewswire

UPDATE -- AP Biosciences to Present New Preclinical Data at American Association of Cancer Research Annual Meeting

22/04/2025 - 05:37

TAIPEI, Taiwan, April 21, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it [...]

Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years

22/04/2025 - 07:00

USD 50 billion commitment includes new state-of-the art research and development (R&D) sites, new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California and an additional site [...]

Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours

22/04/2025 - 07:47

Oslo, Norway, 22 April 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, has successfully developed, scaled and [...]

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

22/04/2025 - 02:00

San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported [...]

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China

22/04/2025 - 02:00

HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has completed enrollment of the registration phase of its [...]

UPDATE -- Opreme Films announces “Just Blood”: A Medical Demonstration Poised to Rewrite Theranos Story

22/04/2025 - 04:02

Ryan El-Hosseiny Declares Elizabeth Holmes Was Right All Along—And Plans to Prove It Live! MIAMI BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- In a moment destined to shake the foundation of modern medicine—and [...]

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

21/04/2025 - 22:05

New system features higher viscoelastic capacity and TruSync™ technology, engineered to safely synchronize surgical control and precision in implant-free, comprehensive MIGS MENLO PARK, Calif., April 21, 2025 (GLOBE [...]

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

21/04/2025 - 22:05

– Former CEO, Marc Forth, to remain as a member of the Company’s Board of Directors – IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage [...]

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025

21/04/2025 - 22:05

CARLSBAD, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2025, before the market opens on [...]

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

21/04/2025 - 22:05

The FDA d esignation m arks a s ignificant m ilestone in the d evelopment of a n ovel t reatment for a r are n eurodevelopmental d isorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate for [...]

Regeneron Announces Investor Conference Presentations

21/04/2025 - 22:05

TARRYTOWN, N.Y., April 21, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) will webcast management participation as follows: BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p. [...]

Clover Health to Participate in Upcoming Investor Conferences

21/04/2025 - 22:05

WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences [...]

Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing

21/04/2025 - 22:05

Study published in the Journal of Clinical Psychopharmacology SALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, [...]

Galapagos Announces Executive Leadership Updates

21/04/2025 - 22:10

Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as founding CEO of newly created SpinCo Dr. Paul Stoffels, Chair and CEO of Galapagos, plans to retire as CEO upon appointment of successor in the next [...]

Bringing clarity and precision to the cell-free space by introducing exozymes

21/04/2025 - 22:10

Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper The author team introduces the terms ‘exozymes’ to bring clarity to the rapidly evolving field of [...]

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

21/04/2025 - 22:10

IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the [...]

LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

21/04/2025 - 22:10

SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2025 earnings [...]

Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

21/04/2025 - 22:15

Company to conduct 1x1 meetings on April 24, 2025 GARDNER, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments [...]

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

21/04/2025 - 22:15

Company to conduct 1x1 meetings on April 24, 2025 GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and [...]